991 related articles for article (PubMed ID: 16483872)
21. Effect of acute activation of 5'-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle.
Miyamoto L; Toyoda T; Hayashi T; Yonemitsu S; Nakano M; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Ogawa Y; Inoue G; Fushiki T; Nakao K
J Appl Physiol (1985); 2007 Mar; 102(3):1007-13. PubMed ID: 17122373
[TBL] [Abstract][Full Text] [Related]
22. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle.
Kramer HF; Witczak CA; Fujii N; Jessen N; Taylor EB; Arnolds DE; Sakamoto K; Hirshman MF; Goodyear LJ
Diabetes; 2006 Jul; 55(7):2067-76. PubMed ID: 16804077
[TBL] [Abstract][Full Text] [Related]
23. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.
Musi N; Goodyear LJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):119-27. PubMed ID: 12476786
[TBL] [Abstract][Full Text] [Related]
24. Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation.
Jørgensen SB; Honeyman J; Oakhill JS; Fazakerley D; Stöckli J; Kemp BE; Steinberg GR
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E57-66. PubMed ID: 19435854
[TBL] [Abstract][Full Text] [Related]
25. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
[TBL] [Abstract][Full Text] [Related]
26. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
27. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.
Goirand F; Solar M; Athea Y; Viollet B; Mateo P; Fortin D; Leclerc J; Hoerter J; Ventura-Clapier R; Garnier A
J Physiol; 2007 Jun; 581(Pt 3):1163-71. PubMed ID: 17446219
[TBL] [Abstract][Full Text] [Related]
28. Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation.
Yu H; Hirshman MF; Fujii N; Pomerleau JM; Peter LE; Goodyear LJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E557-65. PubMed ID: 16638825
[TBL] [Abstract][Full Text] [Related]
29. Chronic activation of 5'-AMP-activated protein kinase changes myosin heavy chain expression in growing pigs.
Park SK; Sheffler TL; Spurlock ME; Grant AL; Gerrard DE
J Anim Sci; 2009 Oct; 87(10):3124-33. PubMed ID: 19617513
[TBL] [Abstract][Full Text] [Related]
30. Alpha2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise.
Miura S; Kai Y; Kamei Y; Bruce CR; Kubota N; Febbraio MA; Kadowaki T; Ezaki O
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E47-55. PubMed ID: 18940938
[TBL] [Abstract][Full Text] [Related]
31. AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle.
Holmes BF; Lang DB; Birnbaum MJ; Mu J; Dohm GL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E739-43. PubMed ID: 15165992
[TBL] [Abstract][Full Text] [Related]
32. Acute exposure to AICAR increases glucose transport in mouse EDL and soleus muscle.
Balon TW; Jasman AP
Biochem Biophys Res Commun; 2001 Apr; 282(4):1008-11. PubMed ID: 11352652
[TBL] [Abstract][Full Text] [Related]
33. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
34. Possible involvement of the alpha1 isoform of 5'AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle.
Toyoda T; Hayashi T; Miyamoto L; Yonemitsu S; Nakano M; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Inoue G; Otaka A; Sato K; Fushiki T; Nakao K
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E166-73. PubMed ID: 15026306
[TBL] [Abstract][Full Text] [Related]
35. Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKalpha.
Qiang W; Weiqiang K; Qing Z; Pengju Z; Yi L
Exp Mol Med; 2007 Aug; 39(4):535-43. PubMed ID: 17934342
[TBL] [Abstract][Full Text] [Related]
36. AMP-activated protein kinase and muscle glucose uptake.
Musi N; Goodyear LJ
Acta Physiol Scand; 2003 Aug; 178(4):337-45. PubMed ID: 12864738
[TBL] [Abstract][Full Text] [Related]
37. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Salt IP; Connell JM; Gould GW
Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
[TBL] [Abstract][Full Text] [Related]
38. Berberine-induced activation of 5'-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles.
Ma X; Egawa T; Kimura H; Karaike K; Masuda S; Iwanaka N; Hayashi T
Metabolism; 2010 Nov; 59(11):1619-27. PubMed ID: 20423742
[TBL] [Abstract][Full Text] [Related]
39. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.
Perrin C; Knauf C; Burcelin R
Endocrinology; 2004 Sep; 145(9):4025-33. PubMed ID: 15192044
[TBL] [Abstract][Full Text] [Related]
40. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle.
Wojtaszewski JF; Jørgensen SB; Hellsten Y; Hardie DG; Richter EA
Diabetes; 2002 Feb; 51(2):284-92. PubMed ID: 11812734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
